Call or Text Us For A Free Case Evaluation: 317.920.6400 | 800.525.8028 Search Site

Another Compounding Pharmacy Recalls Drug

March 26, 2013 Drug Injuries, Products Liability

aspergillus_niger_conClinical Specialties of Martinez, GA., has received reports of eye infections among patients who used the drug to treat macular degeneration, a common vision disorder in seniors.

The Georgia-based compounding pharmacy is recalling 40 lots of the Roche drug Avastin that was distributed to doctors’ offices in Georgia, Louisiana, South Carolina and Indiana since December 18, 2012.

Age-related macular degeneration is the most common cause of blindness among older Americans, affecting about 2 million people in the U.S. over age 50. The condition causes new blood vessels to grow in the eye and leak blood and fluid, damaging the retina and distorting vision.

The FDA has stepped up inspections of compounding pharmacies after a fungal meningitis outbreak last year was tied to the New England Compounding Center in Framingham, Massachusetts. The tainted steroid has killed 50 people and sickened more than 720 across the nation. Since the discovery last September, NECC has shut down.

This week, Margaret A. Hamburg, M.D., Commissioner of the Food and Drug Administration wrote in the FDA blog, “I firmly believe that new legislation is necessary to help FDA effectively oversee firms engaged in widespread distribution of sterile compounded drug products in advance of or without receiving a prescription.” Dr. Hamburg continued on to say, “Protection Americans from unsafe and contaminated drugs is not just an important responsibility for FDA–it is part of our core mission.”

People who have received these recalled drugs should consult with a physician as soon as possible. If you’ve been injured by the product you should contact a product liability or personal injury attorney to discuss your legal rights. You could be compensated for your injuries.

Request A Free Case Evaluation

Fill out the form below to receive a free and confidential initial consultation.

Submitting your information does not automatically create an attorney-client relationship. I agree